I can see that SGEN, INCY, PCYC, BMRN, ENTA, and INSM may be candidates for buyout in the next 24 months.
Just my educated guess--These companies have potential block-buster revenue and big pharmas might need extra revenue to help them guard against the expired patents.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.